Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up.
N MuraliR W BrowneK Fellows MaxwellM L BodziakD JakimovskiJ HagemeierN BergslandB Weinstock-GuttmanRobert ZivadinovMurali RamanathanPublished in: European journal of neurology (2019)
Increases in HDL-C and ApoA-I have protective associations with magnetic resonance imaging measures of neurodegeneration in MS.